Abais-Battad JM, Alsheikh AJ, Pan X et al (2019) Dietary effects on dahl salt-sensitive hypertension, renal damage, and the t lymphocyte transcriptome. Hypertension 74:854–863. https://doi.org/10.1161/HYPERTENSIONAHA.119.12927
Article CAS PubMed Google Scholar
Cheng Y, Zhang J, Guo W et al (2016) Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy. Free Radic Biol Med 93:94–109. https://doi.org/10.1016/j.freeradbiomed.2016.02.002
Article CAS PubMed PubMed Central Google Scholar
Chung HJ (2014) The role of Randall plaques on kidney stone formation. Transl Androl Urol 3:251–254. https://doi.org/10.3978/j.issn.2223-4683.2014.07.03
Article PubMed PubMed Central Google Scholar
D’Costa MR, Haley WE, Mara KC et al (2019) Symptomatic and radiographic manifestations of kidney stone recurrence and their prediction by risk factors: a prospective cohort study. J Am Soc Nephrol 30:1251–1260. https://doi.org/10.1681/ASN.2018121241
Article PubMed PubMed Central Google Scholar
Dong C, Song C, He Z et al (2023) Protective efficacy of Schizandrin B on ameliorating nephrolithiasis via regulating GSK3beta/Nrf2 signaling-mediated ferroptosis in vivo and in vitro. Int Immunopharmacol 117:110042. https://doi.org/10.1016/j.intimp.2023.110042
Article CAS PubMed Google Scholar
Feng Q, Yang Y, Qiao Y et al (2023) Quercetin ameliorates diabetic kidney injury by inhibiting ferroptosis via activating nrf2/ho-1 signaling pathway. Am J Chin Med 51:997–1018. https://doi.org/10.1142/S0192415X23500465
Article CAS PubMed Google Scholar
He Z, Liao W, Song Q et al (2021) Role of ferroptosis induced by a high concentration of calcium oxalate in the formation and development of urolithiasis. Int J Mol Med 47:289–301. https://doi.org/10.3892/ijmm.2020.4770
Article CAS PubMed Google Scholar
Hindricks J, Ebert T, Bachmann A et al (2014) Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction. Clin Endocrinol (oxf) 80:918–924. https://doi.org/10.1111/cen.12380
Article CAS PubMed Google Scholar
Hirose M, Yasui T, Okada A et al (2010) Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney. Int J Urol 17:83–92. https://doi.org/10.1111/j.1442-2042.2009.02410.x
Article CAS PubMed Google Scholar
Hu J, Gu W, Ma N, Fan X, Ci X (2022) Leonurine alleviates ferroptosis in cisplatin-induced acute kidney injury by activating the Nrf2 signalling pathway. Br J Pharmacol 179:3991–4009. https://doi.org/10.1111/bph.15834
Article CAS PubMed Google Scholar
Jia Z, Li W, Bian P et al (2021) Ursolic acid treats renal tubular epithelial cell damage induced by calcium oxalate monohydrate via inhibiting oxidative stress and inflammation. Bioengineered 12:5450–5461. https://doi.org/10.1080/21655979.2021.1955176
Article CAS PubMed PubMed Central Google Scholar
Kirkali Z, Rasooly R, Star RA, Rodgers GP (2015) Urinary stone disease: progress, status, and needs. Urology 86:651–653. https://doi.org/10.1016/j.urology.2015.07.006
Li F, Liu Z, Tang C, Cai J, Dong Z (2018) FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury. FASEB J 32:3423–3433. https://doi.org/10.1096/fj.201701316R
Article CAS PubMed PubMed Central Google Scholar
Li Y, Zhang J, Liu H et al (2019) Curcumin ameliorates glyoxylate-induced calcium oxalate deposition and renal injuries in mice. Phytomedicine 61:152861. https://doi.org/10.1016/j.phymed.2019.152861
Article CAS PubMed Google Scholar
Li J, Cao F, Yin HL et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11:88. https://doi.org/10.1038/s41419-020-2298-2
Article PubMed PubMed Central Google Scholar
Li Z, Chang L, Ren X, Hu Y, Chen Z (2021) Modulation of rat kidney stone crystallization and the relative oxidative stress pathway by green tea polyphenol. ACS Omega 6:1725–1731. https://doi.org/10.1021/acsomega.0c05903
Article CAS PubMed PubMed Central Google Scholar
Lin Z, Zhou Z, Liu Y et al (2011) Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese. PLoS ONE 6:e18398. https://doi.org/10.1371/journal.pone.0018398
Article CAS PubMed PubMed Central Google Scholar
Lu H, Sun X, Jia M et al (2021) Rosiglitazone suppresses renal crystal deposition by ameliorating tubular injury resulted from oxidative stress and inflammatory response via promoting the nrf2/ho-1 pathway and shifting macrophage polarization. Oxid Med Cell Longev 2021:5527137. https://doi.org/10.1155/2021/5527137
Article CAS PubMed PubMed Central Google Scholar
Miess H, Dankworth B, Gouw AM et al (2018) The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene 37:5435–5450. https://doi.org/10.1038/s41388-018-0315-z
Article CAS PubMed PubMed Central Google Scholar
Qiongyue Z, Xin Y, Meng P et al (2022) Post-treatment with irisin attenuates acute kidney injury in sepsis mice through anti-ferroptosis via the sirt1/nrf2 pathway. Front Pharmacol 13:857067. https://doi.org/10.3389/fphar.2022.857067
Article CAS PubMed PubMed Central Google Scholar
Rodgers AL (2017) Physicochemical mechanisms of stone formation. Urolithiasis 45:27–32. https://doi.org/10.1007/s00240-016-0942-1
Shao M, Yu L, Zhang F et al (2015) Additive protection by LDR and FGF21 treatment against diabetic nephropathy in type 2 diabetes model. Am J Physiol Endocrinol Metab 309:E45-54. https://doi.org/10.1152/ajpendo.00026.2015
Article CAS PubMed PubMed Central Google Scholar
Shi YC, Lu WW, Hou YL et al (2018) Protection effect of exogenous fibroblast growth factor 21 on the kidney injury in vascular calcification rats. Chin Med J (england) 131:532–538. https://doi.org/10.4103/0366-6999.226065
Singh P, Harris PC, Sas DJ, Lieske JC (2022) The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol 18:224–240. https://doi.org/10.1038/s41581-021-00513-4
Tang S, Xiao X (2020) Ferroptosis and kidney diseases. Int Urol Nephrol 52:497–503. https://doi.org/10.1007/s11255-019-02335-7
Tian H, Liang Q, Shi Z, Zhao H (2023) Hyperoside ameliorates renal tubular oxidative damage and calcium oxalate deposition in rats through ampk/nrf2 signaling axis. J Renin Angiotensin Aldosterone Syst 2023:5445548. https://doi.org/10.1155/2023/5445548
Article CAS PubMed PubMed Central Google Scholar
Tsujihata M (2008) Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. Int J Urol 15:115–120. https://doi.org/10.1111/j.1442-2042.2007.01953.x
Article CAS PubMed Google Scholar
Wang X, Chen X, Zhou W et al (2022) Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways. Acta Pharm Sin B 12:708–722. https://doi.org/10.1016/j.apsb.2021.10.005
Article CAS PubMed Google Scholar
Weng HC, Lu XY, Xu YP et al (2021) Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism. Mol Med 27:147. https://doi.org/10.1186/s10020-021-00408-x
Article CAS PubMed PubMed Central Google Scholar
Woo YC, Xu A, Wang Y, Lam KS (2013) Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. Clin Endocrinol (oxford) 78:489–496. https://doi.org/10.1111/cen.12095
Wu A, Feng B, Yu J et al (2021) Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. Redox Biol 46:102131. https://doi.org/10.1016/j.redox.2021.102131
Article CAS PubMed PubMed Central Google Scholar
Xie J, Ye Z, Li L et al (2022) Ferrostatin-1 alleviates oxalate-induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis. Mol Med Rep. https://doi.org/10.3892/mmr.2022.12772
Article PubMed PubMed Central Google Scholar
Yang Y, Hong S, Lu Y et al (2022) CAV1 alleviated CaOx stones formation via suppressing autophagy-dependent ferroptosis. PeerJ 10:e14033. https://doi.org/10.7717/peerj.14033
留言 (0)